Ramucirumab in the treatment of non-small cell lung cancer-Reference-Cited by-同舟云学术

Ramucirumab in the treatment of non-small cell lung cancer

Published:2017-04-21 Issue:5 Volume:16 Page:637-644
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Arrieta Oscar¹,Zatarain-Barrón Zyanya Lucia¹,Cardona Andrés F.²³,Carmona Amir¹⁴,Lopez-Mejia Mariana¹

Affiliation:

1. Thoracic Oncology Unit, Instituto Nacional de Cancerologia

2. Clinical and Traslational Oncology Group, Clínica del Country, Bogotá, Colombia

3. Foundation for Clinical and Applied Cancer Research – FICMAC, Bogotá, Colombia

4. Comprehensive Cancer Center, Médica Sur Clinic and Foundation, Mexico

Funder

Instituto Nacional de Cancerologia Mexico

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2017.1313226

Reference70 articles.

1. Cancer statistics, 2017

2. Globocan. estimated cancer incidence, mortality and prevalence worldwide 2012 (online predictor analysis). 2012 [cited 2016; Available from: http://globocan.iarc.fr/Pages/burden_sel.aspx

3. Clinical and Pathological Characteristics, Outcome and Mutational Profiles Regarding Non–Small-Cell Lung Cancer Related to Wood-Smoke Exposure

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of chitosan polyethylene glycol antibody complex for delivery of Imatinib in lung cancer cell lines;Journal of Biochemical and Molecular Toxicology;2024-07-27

2. A real-world study of Afatinib plus ramucirumab in treatment-naïve, EGFR-mutated, non–small cell lung cancer;BMC Cancer;2023-05-08

3. Using a zebrafish xenograft tumor model to compare the efficacy and safety of VEGFR-TKIs;Journal of Cancer Research and Clinical Oncology;2023-01-07

4. The diverse landscape of dermatologic toxicities of non‐immune checkpoint inhibitor monoclonal antibody‐based cancer therapy;Journal of Cutaneous Pathology;2022-10-03

5. circCCT3 Enhances Invasion and Epithelial-Mesenchymal Transition (EMT) of Non-Small-Cell Lung Cancer (NSCLC) via the miR-107/Wnt/FGF7 Axis;Journal of Oncology;2022-06-22